BCRPmRNA andFLT3-ITD are independent poor risk factors in adult patients with acute myeloid leukemia and intermediate or normal karyotype
Author:
Affiliation:
1. Institute of Hematology and Transfusion Medicine; Warsaw Poland
2. Maria Sklodowska-Curie Memorial Cancer Centre and Institute; Warsaw Poland
3. University of Medical Sciences; Poznan Poland
Funder
The Polish Ministry of Science
Publisher
Wiley
Subject
Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12913/fullpdf
Reference31 articles.
1. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials;Grimwade;Blood,2010
2. Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome;Keating;Leukemia,1988
3. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML trial;Grimwade;Blood,1998
4. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials;Kottoridis;Blood,2001
5. Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm;Fröhling;Blood,2002
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype;Journal of Translational Medicine;2022-12-22
2. Update on drug transporter proteins in acute myeloid leukemia: Pathological implication and clinical setting;Critical Reviews in Oncology/Hematology;2021-04
3. Neuroprotective effect of FMS-like tyrosine kinase-3 silence on cerebral ischemia/reperfusion injury in a SH-SY5Y cell line;Gene;2019-05
4. FLT3 Inhibitors as Sensitizing Agents for Cancer Chemotherapy;Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3